The 1st EoETALY Consensus on the Diagnosis and Management of Eosinophilic Esophagitis – Definition, Clinical Presentation and DiagnosisNicola de Bortoli, Edoardo Savarino, Ottavia Bartolo et al.|Digestive and Liver Disease|2024Cited by 53
The 1st EoETALY Consensus on the Diagnosis and Management of Eosinophilic Esophagitis–Current Treatment and MonitoringNicola de Bortoli, Edoardo Savarino, Pierfrancesco Visaggi et al.|Digestive and Liver Disease|2024Cited by 50
Abstract P6-21-13: A phase II single arm trial evaluating the efficacy and safety of eribulin in combination with bevacizumab for second-line treatment of human epidermal growth factor receptor 2 (HER2)–negative metastatic breast cancer (MBC) progressing after first-line therapy with bevacizumab and paclitaxelSabino De Placido, Grazia Arpino, Michelino De Laurentiis et al.|Cancer Research|2019Cited by 0